Baby Powder

The financial toll of this peculiar habit has reached $14 (around Rs 1,100) a day since January, totaling an astonishing $3,780 this year.

‘Not able to sell, what next’: Chemist body asks Johnson and Johnson as FDA orders withdrawal of baby powder from market

Industry experts want the Drug Controller of India to intervene in the matter of J&J baby powder failing the quality test in the country.

'Withdraw baby powder from the market': Maharashtra FDA tells J&J

The order was issued as the product failed the pH test. It does not say anything about the use of asbestos, a carcinogen, in the product, over which Johnson & Johnson faces many lawsuits.

Johnson & Johnson to stop selling talc-based baby powder in US and Canada

The U.S. healthcare conglomerate said it would wind down sales of the product, which makes up about 0.5% of its U.S. consumer health business, in the coming months, but that retailers will continue to sell existing inventory.

States begin testing J&J baby products for cancer-causing agents

Madhya Pradesh officials have collected samples from eight cities in the state. The test results will be sent to India's child rights body National Commission for Protection of Child Rights (NCPCR) by this week.

Top talcum brands under scanner for cancer-causing substances

Maharashtra FDA has taken the lead in conducting the first round of test on sample of HUL's Ponds, Johnson and Johnson's Baby powder and ITC's Shower to Shower brands.

Johnson & Johnson seeks relief from HC on Maha FDA order

In a bid to challenge the Maharashtra FDA decision to cancel license to manufacture cosmetics from the Mulund facility, Johnson and Johnson has moved the Bombay HC, reports CNBC-TV18's Ashmit Kumar.

J&J's Mulund plant loses cosmetic licence

In a big blow for cosmetics major Johnson & Johnson, its appeal was overturned by the Maharashtra State FDA minister.